Suspension of trading
Quotes Oncternal Therapeutics, Inc.
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2024-12-02 EST
|
5-day change | 1st Jan Change | ||
| 0.5266 USD | -24.11% |
|
-.--% | - |
| 25-07-01 | Oncternal Therapeutics, Inc. Appoints Craig R. Jalbert as CEO | CI |
| 25-07-01 | Oncternal Therapeutics, Inc. Announces Management Changes | CI |
Stock exchange
Nasdaq
ONCT 0.5266 $
-24.11%
370K
$
| Markets | Price | Change | Volumes |
|---|
Performance
| 1 day | -24.11% | ||
| 3 years | -91.52% | ||
| 5 years | -99.37% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
1,558,549
Net sales ()
785,000
Number of employees
29
Sales / Employee (USD)
27,069
Free-Float
90.77%
Free-Float capitalization (USD)
1,414,691
Indicators
Moving average 5 days
0.6856
Moving average 100 days
3.068
Price spread / (MMA5)
+30.19%
Price spread / (MMA100)
+482.66%
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -24.11% | -.--% | -.--% | -91.52% | 1.56M | |
| -0.18% | +4.58% | +3.88% | +31.79% | 47.86B | |
| -0.83% | -0.67% | +42.61% | +34.77% | 44.46B | |
| -0.84% | +5.34% | +8.05% | +91.52% | 41.85B | |
| -1.10% | -6.89% | +329.50% | +535.80% | 41.34B | |
| -0.62% | -0.06% | +10.15% | +46.02% | 30.04B | |
| -2.07% | -0.54% | +23.90% | +154.30% | 17.59B | |
| -6.08% | -6.94% | - | - | 15.6B | |
| -3.55% | +3.65% | +21.51% | +38.83% | 15.69B | |
| -0.78% | +11.24% | -10.81% | - | 13.93B | |
| Average | -3.84% | -0.19% | +47.64% | +105.19% | 26.84B | |
| Weighted average by Cap. | -1.07% | +1.88% | +67.06% | +141.32% |
Historical Quotes: Oncternal Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 3 years | 0.53 |  | 13.14 |
| 5 years | 0.53 | | 92.6 |
| 10 years | 0.53 | | 211.2 |
Monthly variations
Annual variations
| 2024 | -95.09% | ||
| 2023 | -46.38% | ||
| 2022 | -55.95% | ||
| 2021 | -53.67% | ||
| 2020 | +24.05% | ||
| 2019 | -43.81% |
- Stock Market
- Stocks
- ONCT Stock
- Quotes Oncternal Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
